Cannabidiol use in women with endometriosis and chronic pelvic pain: a randomized duble-blind clinical trial for evaluation in pan and quality of life

nifesp - Universidade Federal de São Paulo0 个研究点开始时间: 2021年5月28日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Patients diagnosed with endometriosis, with an suggestive image exam, who maintain pain (visual analogue scale more than 5) even in the course of drug treatment with hormonal contraceptives for at least 3 months before the inclusion of the study

•Other types of clinical hormonal treatment (anastrozole, gestrinone, GnRh analogue); patients undergoing complementary treatment with physiotherapy, acupuncture, meditation; patients using other herbal medicines (Uncaria tomentosa); patients planning to become pregnant, pregnant and / or lactating women; patients with allergies to medication components; patients with psychiatric disorders; patients with liver disease, heart disease and / or kidney disease; patients taking medications with potential interactions (clonazepam, n-desmethylclobazam, topiramate, stiripentol, zonizamide, eslicarbazepine, rufinamide)

发起方

nifesp - Universidade Federal de São Paulo